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Metabolic profiling of host tissues and biofluids during parasitic infections can reveal new biomarker
information and aid the elucidation of mechanisms of disease. Themulticompartmental metabolic effects
of an experimental Echinostoma caproni infection have been characterized in 12 outbred female mice
infected orally with 30 E. capronimetacercariae each, using a further 12 uninfected animals as a control
group. Mice were killed 36 days postinfection and brain, intestine (colon, ileum, jejeunum), kidney,
liver, and spleen were removed. Metabolic profiles of tissue samples were measured using high-
resolution magic angle spinning 1H NMR spectroscopy and biofluids measured by applying conventional
1H NMR spectroscopy. Spectral data were analyzed via principal component analysis, partial least-
squares-derived methods and hierarchical projection analyses. Infection-induced metabolic changes
in the tissues were correlated with altered metabolite concentrations in the biofluids (urine, plasma,
fecal water) using hierarchical modeling and correlation analyses. Metabolic descriptors of infection
were identified in liver, renal cortex, intestinal tissues but not in spleen, brain or renal medulla. The
main physiological change observed in the mouse was malabsorption in the small intestine, which
was evidenced by decreased levels of various amino acids in the ileum, for example, alanine, taurine,
glutamine, and branched chain amino acids. Furthermore, altered gut microbial activity or composition
was reflected by increased levels of trimethylamine in the colon. Our modeling approach facilitated
in-depth appraisal of the covariation of the metabolic profiles of different biological matrices and found
that urine and plasmamost closely reflected changes in ileal compartments. In conclusion, an E. caproni
infection not only results in direct localized (ileum and jejenum) effects, but also causes remote metabolic
changes (colon and several peripheral organs), and therefore describes the panorganismal metabolic
response of the infection.
Keywords: Biomarker • Cluster Analysis • Echinostoma caproni • Hierarchical Analysis • Magic Angle
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Introduction
Parasitic infections induce metabolic changes in various
physiological compartments of the host and impact upon both
local and systemic tissue homeostasis. Protozoan parasites
come into physical contact with multiple different tissues in
the host organism, due to widespread distribution in the blood
stages in their life cycle (e.g., Trypanosoma spp. and Plasmo-
dium spp.).1,2 On the other hand, parasitic worms (i.e., helm-
inths, consisting of cestodes, nematodes, and trematodes) are
less likely to come into contact with multiple host tissues, as
the worms are often restricted to a single organ once they have
reached their place of maturation, such as the bile duct
(Fasciola spp.), the lung (Paragonimus spp.) or the small
intestinal tract (Echinostoma spp).3 However, although the
physical presence of the adult worm may be topographically
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limited, there are well-known situations where helminths can
induce pathological states in remote organs, as for example in
the case of neuroschistosomiasis, where parasite eggs are
transported to the central nervous system (CNS) and cause local
inflammation in the tissues in which they embed.4 Another
example is Fasciola hepatica-induced pancreatitis,5 for which
the mechanism has yet to be fully elucidated.
There is increasing awareness of the importance of the
composition and function of the microbiota in many physi-
ological and pathological processes.6,7 Several parasites have
been shown to impact upon host microbial composition or
activity.8-12 For example, Summers and colleagues (2003)13
showed the benefits of a Trichuris suis infection on inflamma-
tory bowel disease (IBD) and highlighted the importance of
monitoring intestinal helminth-induced changes at the mi-
croenvironmental level, especially with respect to the interac-
tions between gut microbiota, host, and parasite. Hence, the
gut deserves special consideration when studying parasite-
induced changes in physiology. This issue is substantiated by
our own observations: approximately a third of all identified
biomarkers in different parasite-rodent models carried out thus
far indicated changes in the microbial composition of the host
gut, and hence, a perturbed microbiome is a characteristic
feature of parasitic infections.8-12,14,15
Gastrointestinal helminth infections represent a considerable
public health and veterinary problem.16,17 Metabolic monitor-
ing of physiological changes due to helminth infections can
deepen our knowledge of direct and remote effects of a
helminth infection on the host and contribute to the elucida-
tion of mechanisms of action at the biochemical level, hence,
leading to a better global understanding of host-parasite
interactions. So far, conventional 1H NMR spectroscopy of
biofluids has been conducted in various host-parasite models
in order to characterize the metabolic signature of an infec-
tion.8-12,14,15 The additional use of high-resolution magic angle
spinning (HR-MAS) delivers a means of nondestructively
analyzing metabolic perturbations in tissues obtained from
many different physiological and pathological states.18-22
Hence, HR-MAS is now an established approach for measuring
semisolid tissues because of its advantages over conventional
1H NMR and magnetic resonance spectroscopy (MRS), which
obtains in vivo spectra21,23,24 and carries complementary
information to biofluid-derived spectral data, but is intrinsically
less sensitive.
In the present study, a metabolic profiling strategy was
employed to characterize the responses of female NMRI mice
to an experimental infection with the intestinal fluke Echinos-
toma caproni. Direct local changes on the small intestine were
investigated, as well as more subtle metabolic changes on the
remote systemic environment of the mouse, for example, brain,
kidney, liver, and spleen. The metabolic signatures of the
E. caproni infection in mice tissue compartments were then
co-analyzed and integrated with existing data from metabolic
changes in biofluids (urine, plasma, and fecal water).11 The
ultimate aim of this work is to provide a more complete global
picture of infection-induced metabolic changes, to model
compartmental interactions, and to further our understanding
of panorganismal metabolic responses of an experimental
infection. Of note, E. caproni represents a suitable model
trematode for study because of its close physical proximity to
the host microbiota and its known and localized impact on
the gut architecture and biochemistry (e.g., fused and eroded
villi and villous atrophy combined with biochemical changes
such as higher concentrations of free fatty acids in the host
mucosa).25,26
Methods
Host-Parasite Model. The study was approved by the
cantonal veterinary authority of Basel (license no. 2081).
Twenty-four female out-bred NMRI mice were purchased from
RCC (Fu¨llinsdorf, Switzerland), housed in groups of 4 in
macrolon cages at the animal care facility of the Swiss Tropical
Institute (Basel, Switzerland), and kept under environmentally
controlled conditions (temperature, ∼25 °C; relative humidity,
60-70%; light-dark cycle, 12-12 h). Mice were acclimatized
for 7 days prior to the start of the experiment, in order to limit
potential stress-related deviation in metabolic profiles. Through-
out the experiment, mice had free access to community tap
water and rodent food purchased from Nafag (Gossau,
Switzerland).
At the start of the experimentsdesignated as day 0smice
were aged 5-6 weeks and had an average weight of 25.5 g
(standard deviation (SD) ) 0.92 g). Mice were split into a
control (n ) 12) and a treatment group (n ) 12), with animals
in the latter group each infected orally with 30 E. caproni
metacercariae (kindly provided by B. Fried; Lafayette College,
PA). Mice were weighed at 7 sequential time points, namely,
days 1, 5, 8, 12, 19, 26, and 33 postinfection, using a Mettler
balance (model K7T; Greifensee, Switzerland). At the same time
points, small amounts of tail blood were collected into sodium-
heparin hematocrit capillaries (40-50 µL) and the packed cell
volume (PCV) was determined as described elsewhere.9 Mice
were killed 36 days postinfection, using CO2. To assess the
worm burden, E. caproni were recovered from the ileum and
jejunum and counted. No worms were found in 4 out of 12
infected animals, and these mice were excluded from further
analysis.
Collection of Tissue Samples. The distal part of the left
lateral lobe of the liver was harvested into a 2 mL cryotube,
immediately immersed in liquid nitrogen, and stored at -80 °C.
The same procedure was followed for the left kidney, the
spleen, and the left half of the brain. Small portions (∼0.5 cm)
of tissue at 3 different locations of the intestine, (i.e., colon,
jejunum, and ileum) were cut from the middle of each section
to avoid regional overlap. Tissue samples were washed with
phosphate buffered saline, then transferred into small cryo-
tubes, immersed in liquid nitrogen, and stored at -80 °C. All
tissues were forwarded to Imperial College (London, U.K.) on
dry ice, and stored at -80 °C prior to preparation for HR-MAS
1H NMR spectroscopy.
Small samples of the 3 intestinal parts, the liver, the right
kidney, the right half of the brain, and the spleen, were
transferred into 5 mL tubes containing a solution of 4%
buffered formalin for subsequent histological analyses via
hematoxylin and eosin staining.
Collection of Biofluids. Details of the collection, processing
and spectral analyses of biofluids have been presented else-
where.11 For the current study, only those biofluid samples (i.e.,
urine, plasma, and fecal water) collected on day 33 postinfec-
tion, which is the closest-matching time point to that when
tissues were sampled (i.e., 36 days postinfection), were
considered.
Preparation and NMR Spectroscopy of Tissues. Tissue
samples of 15-20 mg were placed in 4-mm outer diameter
zirconia rotors (Bruker Analytische Messtechnik GmbH; Rhein-
research articles Saric et al.
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stetten, Germany), to which a drop (∼50 µL) of 0.9% saline D2O
was added and enclosed with a spherical insert and a Kel-F
cap.
The 1H NMR spectra of all tissues were acquired on a Bruker
DRX600 spectrometer operating at 600.13 MHz (14.1 T) and
spun at a MAS rate of 5000 Hz. A constant temperature of 283 K
was maintained during spectral acquisition by cooling the inlet
gas, which is responsible for sample spinning and surveyed by
the thermocouple system. One-dimensional (1D) 600 MHz 1H
NMR spectra were acquired using the standard solvent sup-
pression pulse sequence [recycle delay (RD)-90°-t1-90°-tm-90°-
acquire free induction decay (FID)]27 to suppress baseline
distortions caused by the large water signal. In this pulse
program, a weak irradiation pulse was applied at the water
resonance frequency during the RD of 3 s and during the
mixing period tm (100 ms), with t1 fixed at 3 µs. Typically, 128
transients were collected into ∼32 600 data points, with a
spectral width of 20 ppm and an acquisition time per scan of
1.36 s.
Two additional NMR experiments were used to analyze
tissue samples. The 1D Carr-Purcell-Meiboom-Gill (CPMG)
spin-echo experiment [RD-90°-(τ-180°-τ)n-acquire FID] takes
advantage of the short transverse relaxation times (spin-spin
relaxation, T2) of macromolecules, and hence can be used to
edit out interfering broad resonances.28 The diffusion-edited
experiment using the bipolar-pair longitudinal-eddy-current
delay (BPP-LED) pulse sequence [RD-90°-G1-τ-180°-G2-τ-90°-
∆-90°-G3-τ-180°-G4-τ-90°-te-90°-acquire FID]29 selectively at-
tenuates signals from small molecules which have fast trans-
lational diffusion rate, and hence enhances the contribution
from high molecular weight molecules.30 Assignment of reso-
nance peaks was achieved via 2-dimensional (2D) 1H-1H
correlation spectroscopy (COSY)31 and total correlation spec-
troscopy (TOCSY)32 for selected samples and by statistical total
correlation spectroscopy (STOCSY) performed on the whole 1D
spectral data set.33
Data acquisition of biofluids was performed as described in
our previous work.11
Data Processing of NMR Spectra. The 1H NMR spectra of
the tissues and biofluids were phased and baseline-corrected
with an in-house developed script and were referenced to the
chemical shift of the -CH3 resonance of alanine at δ 1.48 in
XwinNMR 3.5 (Bruker Analytische Messtechnik GmbH; Rhein-
stetten, Germany). The signal intensity in each spectrum was
calculated by the integration of 0.00025 ppm wide sections. The
region containing the water resonance (δ 4.7-5.1) was removed
and the spectra were converted into ∼28 000 data points over
the range of δ 0.5-8.0 using MATLAB (Version 7; The Math-
works Inc.; Natwick, MA). Before pattern recognition analysis
was performed, each spectrum was normalized to the total
remaining spectral area in a MATLAB environment.
Multivariate Analysis of NMR Data. Principal component
analysis (PCA) was applied to the 1H NMR spectral data sets
for individual tissues in order to give an overview of the data
distribution and intersample similarities (e.g., groupings and
outliers) for each tissue.34,35 The descriptive components of the
PCA models R2X and Q2cumX indicate the explanatory and the
predictive power of each model, respectively. Partial least-
squares analysis (PLS) was subsequently applied to each matrix
to optimize biochemical discrimination of the tissues from
uninfected control and E. caproni-infected mice. This method
quantitatively relates the data matrix X to the Y-matrix contain-
ing additional information regarding a measure of response,
in this case the number of worms recovered, and thus correlates
the worm burden to the metabolic profiles. PLS can also be
applied as qualitative measure in discriminant analyses (PLS-
DA), whereby the second set of information (Y) contains a 0
or 1 coded matrix representing classification values, such as
gender, presence or absence of infection, and so forth.36
Further modification of the PLS-DA algorithm has been
made using an in-built orthogonal filter to split the variation
in the NMR data into 3 parts, that is, (i) real intermatrix
correlation, (ii) systematic variation relating to the Y-matrix only
(i.e., class of sample), and (iii) residual variation related to noise
and/or baseline imperfections.36 This method of deconvolving
the NMR data enables the exclusion of the latter 2 sources of
variation from the modeling process and optimizes interpreta-
tion with respect to elucidating the effects that are directly
related to infection. Further to this initial analysis on individual
matrices, hierarchical PLS-DA (H-PLS-DA) was applied as a
statistical aid for facilitating visualization and information-
recovery from this complex multidimensional data set with
emphasis on interrogating similarities and dissimilarities in
response to infection across locally distinct tissues and organs.
This method has previously been applied to NMR-spectral data
sets to elucidate biological events on molecular, compartmen-
tal, and systems levels.37 The sublevel of hierarchical analysis
was built initially using PCA models for each of the investigated
compartments, referred to as independent blocks and the
derived scores tB for each tissue matrix was subsequently
combined to deliver a new analytical template or ‘superblock’
of all significant principal component (PC) scores for all tissues
that can be modeled by PCA or PLS.38 The number of PCs
included in the superblock was determined according to the
optimal Q2X values (representing the predictivity of each
model). A total of 34 independent blocks were chosen from
the first analytical level and are comprised of the biological
compartments liver, ileum, colon, renal cortex, plasma, and
urine acquired by up to 3 different pulse programs (i.e., 1D
standard, CPMG, diffusion-edited). The explanatory power of
each data set (defined by a particular type of NMR pulse
program as applied to an individual tissue type or compart-
ment, e.g., CPMG spectra for liver, etc.), that is, Q2X values and
visual differentiation between the infected and controls in the
scores, was used to select the scores tB for building a new
analytical template for hierarchical analysis. H-PLS-DA analysis
delivers new compound scores tT based on the new descriptor
variables (e.g., PC scores for each tissue) and the loadings pT,
generated for this supralevel show the relative contribution of
each tissue or biofluid compartment to groupings observed in
the scores plot.39,40
Correlation Analysis of Selected Physiological Com-
partments. To assess the degree of interaction between bio-
logical compartments, which showed an E. caproni-induced
alteration of the metabolic profile, an O-PLS-based correlation
analysis was performed. For each compartment, metabolites
that differentiated between control and infected groups, with
a cutoff correlation coefficient of 0.55 for a group size of 8
animals, were selected and integrated over a nonoverlapped,
representative peak region using the trapezium rule41 for
further correlation analysis. This procedure was repeated for 8
selected compartments (urine, plasma, fecal water, liver,
kidney, ileum, jejunum, and colon) demonstrating differentia-
tion between infected and control profiles and pairwise cor-
relations were calculated for each integrated metabolite. The
pairwise correlations between changes in metabolite concen-
Panorganismal Metabolic Response Modeling research articles
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trations, taking all differentiating biological matrices into
account, were calculated using the Pearson correlation coef-
ficient measure. The p-values for testing the null hypothesis
(i.e., no correlations between tissue localized metabolites) were
computed by t-statistics using n - 2 degrees of freedom. Each
p-value is the probability of observing a correlation between
the assessed metabolic concentrations, that is, integrated area,
as large as the observed value by random chance, when the
true correlation is zero. The correlations between metabolite
concentration changes with p < 0.05 were used in the analysis.
The metabolite correlation matrix was clustered using average
linkage hierarchical clustering coupled with the correlation
dissimilarity measure to identify subsets of highly correlated
changes in metabolite concentrations relating to the infection
induced response.
Results
Physiological Monitoring of Mice, Gross Parasite Bur-
den, and Histology. Mice that were infected with E. caproni
for up to 36 days showed no visible signs of ill-health.
Moreover, their mean weight and mean PCV showed no
significant difference to the uninfected control group at any
time point, indicating that the mice had not become anemic
as a result of the infection. Worms were recovered and counted
after dissection of mice, in order to confirm and assess the level
of infection. Worms were present in 8 out of the 12 mice
initially infected (average worm count ) 26.5; SD ) 12.0; range
) 10-44 worms). Only animals with an established infection
were included in subsequent analyses. Histological analysis of
the spleen, kidney, liver, brain, ileum, jejunum, and colon did
not show any infection-induced abnormalities in the cellular
architecture.
Analysis of Biofluids from E. caproni-Infected Mice. Time-
induced changes associated with an E. caproni infection in the
metabolic profiles of mouse urine, plasma, and fecal water have
been reported elsewhere.11 In brief, the dominant infection-
related changes in the biofluids collected at the final time point
(day 33 postinfection) included decreased hippurate and
increased levels of trimethylamine in urine, evidence of in-
creased lipids in the plasma, and higher excretion of several
amino acids in the feces.
Tissue-Specific Metabolic Composition in Healthy Mice.
The biochemical composition of the various organs and tissues
analyzed in the noninfected cohort was consistent with the
extant literature.20,22,23 Lactate, choline, and alanine, the
branched chain amino acids (BCAAs), glutamine, glutamate,
betaine, and taurine were observed in all tissue samples (Figure
1), while other metabolites were more apparent in specific
tissues only. For example, liver spectra contained generally
higher glucose levels than the kidney and the small intestinal
tissues (ileum and jejunum), while the spleen and colon
showed practically no visible glucose resonances. Furthermore,
the assessed liver and ileum regions contained the highest
concentration of lipid components compared to the other
tissues, whereas ileum and jejunum showed the highest levels
of tyrosine and phenylalanine of all measured tissues. The
spleen and kidney spectra contained particularly low relative
levels of both these amino acids. As expected, comparison of
kidney medulla with cortical tissue showed higher concentra-
tions of osmotically active substances, such as betaine, myo-
and scyllo-inositol, and taurine, together with higher levels of
glycerophosphocholine (GPC), choline, creatine, and glucose
in the medulla.
The spectral comparison of the colon with the 2 small
intestinal tissues jejunum and ileum indicated that the main
histological difference between these regions was the short
chain fatty acid (SCFA) levels. For example, butyrate and
propionate were only present in appreciable concentrations in
the colon (data not shown). Lipid signals were strongest in
ileum and weakest in colon. Acetate was found in all 3 intestinal
regions, with highest levels in the colon. The various metabo-
lites detected in different tissue samples are summarized in
Table 1.
Pairwise Comparison Between E. caproni-Infected and
Uninfected Control Mice for Each Biocompartment and
Correlation of Metabolite Profiles with Worm Burden. The
R2 and Q2 values for all the sublevel mathematical models are
summarized in Table 2. Differentiation between control and
infected groups was observed for all tissues examined, except
renal medulla, brain, and spleen. A candidate set of biomarkers,
representing the impact of an E. caproni infection on mouse
tissues, was recovered using O-PLS-DA for all discriminatory
data sets. Table 2 shows the Q2Y values, indicating the quality
of each of the models corresponding to individual tissues. In
the liver, betaine and phosphocholine levels were significantly
higher in E. caproni-infected compared to uninfected control
mice (Figure 2), while the BCAA concentrations were decreased
in several matrices (i.e., liver, plasma, and ileum) after infection,
with a corresponding increase of these metabolites observed
in fecal water (Table 1). Assessment of the correlation of worm
Figure 1. Typical 600 MHz 1H MAS NMR 1D spectra of different
tissues from an uninfected control mouse, aged 8 weeks, (I) liver,
(II) kidney cortex, (III) spleen, and (IV) ileum. Key: 1, -glucose;
2, glycerophosphocholine; 3, phosphocholine; 4; lactate; 5,myo-
inositol; 6, choline; 7, creatine; 8, betaine; 9, glycine; 10, taurine;
11, aspartate; 12, asparagine; 13, glutamine; 14, glutamate; 15,
acetate; 16, triglyceride (CHdCH); 17, lysine; 18, alanine; 19,
methionine; 20, trimethylamine-N-oxide (TMAO); 21, valine; 22,
isoleucine; 23, leucine; 24, triglyceride (CH)3; 25, triglyceride (CH)2;
26, triglyceride (CH2CH2CO); 27, triglyceride (CHdCHCH2); 28,
triglyceride (CH2CO).
research articles Saric et al.
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burden with the spectral changes achieved via O-PLS modeling
revealed an association of hepatic glutamate with worm burden
(R2Y ) 0.92, Q2Y ) 0.43), in addition to those metabolites
simply associated with presence or absence of infection.
GPC was found to be decreased in the renal cortex of
E. caproni-infected mice, whereas alanine, aspartate, scyllo-
inositol, and glutamate were increased in the infected group
(Figure 2).
The renal medulla, brain, and spleen showed no infection-
related metabolic changes at all based on PCA modeling, which
is underscored by the low Q2Y values as shown in Table 2 for
these models. However, O-PLS analysis of the renal medulla
using worm burden as the Y or response variable data gave an
overall model with an R2Y value of 0.55 and a Q2Y value of 0.29
and identified an inverse correlation of betaine with the worm
burden, whereas the lipid components were positively cor-
related with the infection intensity. Since the PCA model for
the renal medulla was not robust, this matrix was not further
analyzed in the hierarchical models.
The intestinal tissues showed significant changes with worm
burden in all 3 assessed regions. The relative concentrations
of 2 aromatic amino acids (e.g., phenylalanine and tyrosine)
were higher in the jejunum of infected mice (Figure 2),
compared to the uninfected control group, and also positively
correlated with worm burden (R2Y ) 0.76, Q2Y ) 0.55).
Conversely myo-inositol and taurine decreased with infection,
but showed no obvious correlation with worm burden. Infec-
tion with E. caproni also induced various metabolic changes
Table 1. Metabolites Found in Different Organs of NMRI Female Mice, Aged 7-8 Weeksa
metabolite coupling pattern (Hz) δ (ppm) infection induced changes
2-ketoisocaproate CH2, CH, 2xCH3 2.61 (d), 2.10 (m), 0.94 (d) (1)U
5-aminovalerate 5-CH2, 2-CH2, 3,4-CH2 3.02 (t), 2.24 (t), 1.65 (m) (2)F
acetate CH3 1.91 (s) (1)P
alanine R-CH, -CH3 3.81 (q), 1.48 (d) (2)Kc, (1)I
ascorbate CH, R-CH, -CH2 4.52 (d), 4.03 (ddd), 3.75 (dd) (1)I
asparagine R-CH, half -CH2, half -CH2 3.90 (dd), 2.81 (dd), 2.69 (dd)
aspartate R-CH, half -CH2, half -CH2 3.90 (m), 2.81 (dd), 2.68 (dd) (2)Kc, (1)I
betaine CH2, CH3 3.90 (s), 3.27 (s) (2)L, (1b)Km
butyrate R-CH2, -CH2, γ-CH3 2.16 (t), 1.56 (m), 0.90 (t)
choline 3xCH3, R-CH2, -CH2 3.21 (s), 4.07 (m), 3.52 (m) (1)P
creatine CH3, CH2 3.04 (s), 3.93 (s) (1)P
formate CH 8.45 (s) (2)P
fumarate CH 6.53 (s) (1)I
glutamate R-CH, -CH2, γ-CH2 3.78 (m), 2.06 (m), 2.36 (m) (2)Kc, (2b)L
glutamine R-CH, -CH2, γ-CH2 3.78 (m), 2.15 (m), 2.46 (m) (1)I
glycerophosphocholine 3xCH3, half R-CH2, half R-CH2,
half -CH2,
3.23 (s), 4.32 (t), 3.60 (dd), 3.68 (t), (1)Kc, (2)C, (2)I,
half -CH2, γ-CH2 3.89 (m), 3.72 (dd) (1)P
glycine CH2 3.55 (s) (1)I
hippurate CH2, 2,6-CH, 3,5-CH, 4-CH 3.97 (d), 7.84 (d), 7.55 (t), 7.64 (t) (1)U
isoleucine R-CH, -CH, half γ-CH2, half
γ-CH2, δ-CH3, -CH3
3.68 (d), 1.93 (m), 1.25 (m), 1.47 (m), 0.99 (d),
1.02 (d)
(1)I, (1)L, (1)P
lactate CH, CH3 4.12 (q), 1.33 (d)
leucine R-CH, -CH2, γ-CH, δ-CH3, δ-CH3 3.72 (t), 1.96 (m), 1.63 (m), 1.69 (m), 0.91 (d),
0.94 (d)
(1)L, (1)P
lysine R-CH, -CH2, γ-CH2, δ-CH2, ε-CH2 3.77 (t), 1.92 (m), 1.73 (m), 1.47 (m), 3.05 (t)
myo-inositol 1,3-CH, 2-CH, 5-CH, 4,6-CH 3.53 (dd), 4.06 (t), 3.28 (t), 3.63 (t) (1)J
phenylacetylglycine 2,6-CH, 3,5-CH, Ph-CH2, N-CH2 7.43 (m), 7.37 (m), 3.75 (d), 3.68 (s) (2)U
phenylalanine 2,6-CH, 3,5-CH, 4-CH, CH2, CH 7.44 (m), 7.39 (m), 7.33 (m), 3.17 (dd), 3.30 (dd),
3.99 (dd)
(2)J
phosphocholine CH3, R-CH2, -CH2 3.24 (s), 3.60 (m), 4.18 (m) (2)L
propionate CH2, CH3 2.19 (q), 1.06 (t)
scyllo-inositol 6xCH 3.35 (s) (2)Kc
taurine CH2N, CH2S 3.27 (t), 3.43 (t) (1)I, (1)J
trimethylamine 3xCH3 2.88 (s) (2)C, (2)U
trimethylamine-N-oxide 3xCH3 3.27 (s)
tyrosine 2,6-CH, 3,5-CH, CH2, R-CH 7.20 (d), 6.91 (d), 3.95 (dd), 3.20 (dd), 3.06 (dd) (2)J
uracil 5-CH, 6-CH 5.81 (d), 7.59 (d) (1)I
valine R-CH, -CH, γ-CH3, γ′-CH3 3.62 (d), 2.28 (m), 0.98 (d), 1.03 (d) (1)I, (1)L, (1)P
R-glucose 1-CH, 2-CH, 3-CH, 4-CH, 5-CH,
half 6-CH2, half 6-CH2
5.24 (d), 3.56 (dd), 3.70 (t), 3.40 (t), 3.83 (m),
3.72 (dd), 3.85 (m)
(2)I, (2)P
-glucose 1-CH, 2-CH, 3-CH, 4-CH, 5-CH,
half 6-CH2, half 6-CH2
4.65 (d), 3.25 (dd), 3.47 (t), 3.40 (t), 3.47 (ddd),
3.78 (dd), 3.90 (dd)
(2)I, (2)P
lipid fractions CH3 0.90 (t) (2)P, (2b)Km
(CH2)n 1.20 (m)
CH2CdC 1.97 (m), 2.00 (m)
CH2CO 2.23 (m)
C)CCH2CdC 2.72 (m)
CHdCH 5.29 (m)
a The arrows indicate the direction of the metabolic change, associated with an E. caproni infection, e.g., significantly increased (2) or decreased (1) in
infected animals compared to noninfected control animals. Key: C, colon; F, feces, Kc, renal cortex; Km, renal medulla; L, liver; I, ileum; J, jejenum; P,
plasma; U, urine. Multiplicity: s, singlet; d, doublet; dd, doublet of doublets, ddd, doublet of doublets of doublets; t, triplet; m, multiplet; q, quadruplet.
b Correlation with infection intensity.
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in the ileum, such as increased glucose and decreased con-
centrations of glycine, fumarate, uracil, taurine, alanine, as-
partate, valine, glutamine, ascorbate, and isoleucine (Figure 2).
A negative correlation to the worm burden was confirmed for
fumarate, ascorbate, glycine, taurine, and alanine (overall
model statistics: R2Y ) 0.74, Q2Y ) 0.24). In the colon, higher
levels of trimethylamine and GPC were observed in the
E. caproni-infected mice.
Multivariate Sublevel and Hierarchical Systems Analysis.
On the basis of the PCA models for each biocompartment, a
second level or hierarchical analysis was performed to assess
intercompartmental correlations characteristic of an E. caproni
infection. Those models that resulted in positive Q2X values
(Table 2) when comparing infected and controls, and achieved
clear visual separation in the corresponding scores plot after
the first sublevel PCA analysis, were chosen for incorporation
into the hierarchical analysis. In the liver, separation between
the metabolic profiles of E. caproni-infected and uninfected
control mice was achieved for each of the applied pulse
programs with PCA (Figure 3) and PLS-DA indicating that both
low molecular weight molecules and the macromolecular
compounds were discriminatory with regard to infection status.
Visual differentiation of renal cortical samples between infected
and uninfected mice were obtained in PCA of the CPMG-
acquired data (Figure 3), but not in the standard or diffusion
edited data, indicating that the key discriminatory molecules
were low molecular weight components. In contrast, the renal
medulla, brain, and spleen showed no infection-related separa-
tion. All 3 intestinal tissues revealed clear infection-induced
differences. In the ileum, PCA models for standard 1D and
CPMG (Figure 3), but not diffusion edited spectra were
significant, and the PLS-DA, via CPMG-acquired spectra de-
livered a good discriminatory model, again implicating the
relatively stronger role of the lower molecular weight molecules
in comparison with the lipidic or membrane components.
Similarly, the class differences in colon were obvious when
employing standard 1D and CPMG-acquired spectra in PCA.
In the case of the jejunal portion of the small intestine, only
the CPMG spectra showed class-separation in PCA. One animal
(denoted by ‘t2’) appeared as an outlier in the scores plots of
the ileum analysis, which might be explained by the fact that
the highest worm burden was observed in this animal (i.e., 44
adult E. caproni worms recovered upon mouse dissection).
For hierarchical modeling of the different tissue compart-
ments, 34 scores vectors tB from previous individual PCA
models were used to form a new analytical template and
included 3 PCs (scores vectors tB) for all of the included
compartments and applied pulse programs with the exception
of the plasma spectra acquired via the standard pulse sequence
and diffusion-edited liver spectra, where 2 PCs were sufficient
to explain the optimal variation in the data set. For liver and
ileum, spectral data from all 3 applied pulse programs could
be further used for hierarchical analysis, whereas in colon,
separation was gained in spectral data derived only from the
1D and CPMG pulse-sequences. Additionally, the renal cortical
PCs from the CPMG acquisition were modeled. The PCA model
for the spleen showed no visual separation in the sublevel PCA
scores plot (Figure 3), but the explained variation in the CPMG-
derived spectral analysis was good, and hence the scores tB were
incorporated in the H-PLS-DA model.
Among the multivariate statistical models for the biofluids,
PCA models of the plasma and urine obtained at the ultimate
sampling time point (i.e., day 33 postinfection) acquired by the
standard 1D pulse sequence showed good separation in the
Table 2. Q2 and R2 Values Are Provided for All Created Analytical Models, Whereas Q2 Is an Indicator of Model-Predictability and
Represents the Quality of the Modela
PCA PLS-DA O-PLS-DA
Q2X R2cumX Q2Y R2X R2Y Q2Y R2Y
Brain standard 1D 0.64 0.71 -0.21 0.24 0.72 -0.03 0.74
Colon standard 1D 0.93 0.96 0.31 0.81 0.68 0.15 0.64
CPMG 0.89 0.94 0.42 0.78 0.78 0.13 0.84
diff. editedb 0.40 0.58 0.13 0.31 0.75 0.03 0.78
Ileum standard 1D 0.74 0.84 0.70 0.50 0.88 0.54 0.85
CPMG 0.72 0.80 0.66 0.53 0.88 0.32 0.75
diff. edited 0.83 0.90 0.05 0.50 0.76 0.20 0.77
Jejenum standard 1Db 0.86 0.88 0.25 0.64 0.53 0.46 0.80
CPMGb 0.71 0.83 0.29 0.43 0.67 0.51 0.78
diff. editedb 0.90 0.93 0.46 0.70 0.63 0.35 0.75
Liver standard 1D 0.85 0.91 0.66 0.71 0.79 0.73 0.87
CPMG 0.81 0.88 0.57 0.69 0.78 0.52 0.94
diff. edited 0.86 0.90 0.60 0.58 0.78 0.57 0.91
Plasma standard 1D 0.76 0.83 0.80 0.68 0.87 0.73 0.98
CPMG 0.62 0.77 0.78 0.42 0.92 0.54 0.96
diff. editedb -0.60 0.25 -0.19 0.16 91.00 0.63 0.94
Renal cortex standard 1D 0.70 0.83 0.15 0.49 0.68 0.25 0.72
CPMGb 0.44 0.71 0.38 0.38 0.85 0.50 0.88
diff. editedb 0.50 0.64 -0.21 0.22 0.83 0.28 0.89
Renal medulla standard 1Db 0.74 0.85 -0.21 0.33 0.65 -0.20 0.51
CPMGb 0.53 0.71 0.29 0.55 0.86 0.14 0.77
diff. editedb 0.50 0.72 0.14 0.34 0.74 0.05 0.79
Spleen standard 1Db 0.89 0.93 -0.21 0.72 0.58 -0.70 0.57
CPMGb 0.70 0.85 0.04 0.50 0.80 0.06 0.74
Urine standard 1D 0.24 0.62 0.37 0.42 0.77 0.73 0.96
a R2 shows how much of the variation in X and Y, respectively, is explained. b Models were excluded from hierarchical analysis due to lack of
discrimination of infected and control group.
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scores plots and, additionally, the CPMG-acquired spectra for
plasma were included in the hierarchical model. H-PLS-DA
analyses were based on the new 34-descriptor template and
were optimally modeled by 2 PCs (PLS-DA: R2X ) 0.35, Q2Y )
0.76). In the H-PLS loadings plot (Figure 4), the main source
of variation corresponding to the 2 separate classes (infected
and noninfected control) in the scores plot lay in differentiation
of the pulse programs rather than the biological compartments
(Figure 4). Thus, the 1D and diffusion-edited experiments for
all biological compartments (with the exception of the 1D
plasma and urine and the diffusion-edited ileum spectral
information) co-mapped with the control animals, whereas the
spectra acquired by the CPMG pulse sequence predominantly
influenced the animals infected with E. caproni, again indicat-
ing the relatively greater contribution of the low molecular
weight components to the characterization of E. caproni
infection.
Calculation of Intercompartment Correlation Structures.
Three separate correlation matrices were calculated using
integral values for all metabolites, which were identified as
discriminatory between uninfected control and E. caproni-
infected mice in particular tissues. These matrices were cal-
culated for (i) control group only (Figure 5A); (ii) infected group
only (Figure 5B); and (iii) the difference in metabolite pairwise
correlations between control and infected groups (Figure 5C).
The correlation matrix constructed for the control data set
showed several positive and negative correlations between
paired metabolites. The greatest number of infection-induced
perturbed metabolite levels occurred in the ileum (n ) 11), the
plasma (n ) 8) and kidney (n ) 5), while only a single
metabolite, that is, 5-aminovalerate, was statistically altered in
the fecal water profile. The colon showed significant changes
in the levels of just 2 metabolites after infection. In some
matrices, such as urine and ileum, the discriminatory bio-
markers, in general, co-varied (either positively or negatively)
within that matrix. In other matrices such as the kidney, the
key infection discriminating metabolites did not show strong
within-matrix correlations. The correlation matrix was struc-
tured using a clustering algorithm indicating patterns of
similarity and dissimilarity between metabolites regardless of
their topographical location (Figure 5A-C). For the control
group, several ileal amino acids (alanine, valine, leucine,
aspartate, and glycine) demonstrate positive correlations. The
GPC level in the colon was correlated with GPC in the plasma
and was also positively associated with plasma lipids, whereas
ileal GPC was negatively correlated with the ileal amino acids.
The correlation matrix calculated for the infected group (Figure
5B) showed conservation of some pairwise correlations (e.g.,
ileal BCAAs and alanine) observed for the control data set, but
the correlations for other metabolite pairs observed in the
control case disintegrated (e.g., GPC levels in the plasma and
colon) and new infection-dependent associations were formed,
such as those between glutamate and myo-inositol in the
jejunum or urinary hippurate and hepatic BCAAs. The differ-
ences in the underlying structure of metabolite correlations
between the control and infected groups are further under-
scored in Figure 5C, which illustrates the differential cluster
matrix of E. caproni-induced effects.
Figure 2. Selected HR-MAS 1H NMR spectral regions in liver, renal cortex, jejunum, and ileumO-PLS-DA analysis. For illustrative purposes,
a standard 1D pulse program was chosen for spectral analysis in liver, kidney and the jejunum aromatic region, whereas the CPMG
data expressed the low molecular weight components, which mainly accounted for class differentiation in the ileum and the aliphatic
region of the jejunum. The color bars indicate maximal contribution of the class separating metabolites in arbitrary units (a.u.).
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Discussion
The systemic effect of an E. caproni infection in the mouse
was reflected in 5 of the 8 host tissues examined and in all 3
biofluids (urine, plasma, and fecal water) investigated. Since
no overt tissue damage was revealed by histology, the observed
alterations in biochemistry associated with an E. caproni
infection can be deemed to be subpathological. As expected,
the tissue which was most affected in terms of the number of
perturbed metabolites was the ileum, since the small intestine
is the primary target location of E. caproni. The infection-
induced metabolic changes suggested a malabsorption in the
ileum reflected by low ileal concentrations of the BCAAs,
taurine, ascorbate, alanine, uracil, and glutamine and may
suggest an impairment of the Na+-coupled co-transporters,
which are the main form of cross-luminal transport in the small
intestinal tract.42 A host of transporter molecules have been
summarized previously,43 whereby 3 main groups were identi-
fied: (i) B0AT1/SLC6A19 for neutral amino acids44 (e.g., valine,
alanine, and isoleucine), which cluster in the correlation map
(Figure 5B); (ii) SLC1A145 for co-transport of anionic amino acid
(e.g., aspartate); and (iii) B0,+ATB0,+/SLC6A14, which is respon-
sible for neutral and cationic amino acid co-transport (e.g.,
glutamine).46 Additionally, taurine, ascorbate, and uracil deple-
tion in the small intestinal tissues can be explained by a
disruption of Na+-coupled transport mechanisms.47,48 A po-
tential intestinal malabsorption has already been suggested in
our previous research focusing on biofluids obtained from
E. caproni-infected mice,11 whereby increased BCAA concen-
tration was observed in the feces and subsequently decreased
BCAA concentration in plasma. Here, the depletion of serum
BCAAs was consistent with the relatively lower ileal and liver
concentrations of these metabolites. The jejunal portion of the
small intestine showed increased concentrations of the aro-
matic amino acids, tyrosine and phenylalanine, which are
oxidized in the liver to phenylacetate and p-hydroxyphenylac-
etate, respectively, and are then converted into p-cresol by gut
microbial species (e.g., Clostridium difficile and Clostridium
scatologenes).49 Since p-cresol undergoes phase II conjugation
to the glucuronide or sulfate in the kidney prior to excretion
via urine, this might explain the higher concentrations of
p-cresol glucuronide found in the urine of E. caproni-infected
mice, which was significantly elevated at time points prior to
day 33 postinfection.11
E. caproni infection-induced changes in the mouse colon
included relatively higher levels of trimethylamine (TMA),
which again may reflect altered microbial activity, as dietary
methyl components such as carnitine and choline are degraded
to TMA by gut bacterial species.50 TMA is bound to lipoproteins
after transluminal transport and reaches the liver via blood
circulation where it is oxidized to trimethylamine-N-oxide
(TMAO).51 Both choline degradation products (TMA and
TMAO) exhibited a higher urinary excretion in the infected
animals, which might be reflective of a systemic increase in
these products. Furthermore, relatively higher levels of GPC
were found in infected mice, which may be due to the reported
E. caproni-induced degradation of host membranes.25 This
observation is further supported by the previously identified
increase of lipid fractions (e.g., fatty acids, triacylglycerides, and
lipoproteins) in the plasma of infected mice.11 We hypothesize
that the significantly higher levels of phosphocholine, with
subsequent betaine production in the liver, and the increase
of inositol and lipid fractions in the kidney, compensate for
the intestinal lipid degradation by increased uptake and
depletion of plasma choline.52-55 Hierarchical multivariate
analysis revealed that the main source of variance in the
combined data set, in connection to the response to infection,
Figure 3. PCA scores plots for liver, renal cortex, spleen, and ileum spectra acquired by a CPMG pulse sequence, showing E. caproni
infection-related differentiation in all assessed host tissues apart from the spleen, which did not show any changes induced by the
infection. The renal cortex spectra of two uninfected control mice (c3 and c6) were excluded from the PCA model due to unsatisfactory
water suppression.
research articles Saric et al.
3906 Journal of Proteome Research • Vol. 8, No. 8, 2009
D
ow
nl
oa
de
d 
by
 IM
PE
RI
A
L 
CO
LL
 L
O
N
D
O
N
 o
n 
O
ct
ob
er
 1
6,
 2
00
9 
| ht
tp:
//p
ubs
.ac
s.o
rg 
 
Pu
bl
ic
at
io
n 
D
at
e 
(W
eb
): 
Ju
ne
 2,
 20
09
 | d
oi:
 10
.10
21/
pr9
001
85s
was mainly accounted for by changes in the low molecular
weight tissue components (e.g., intestinal malabsorption of
amino acids) as the spectral data acquired via the CPMG pulse
sequence, which seems to drive the mapping position of the
infected group in the metabolic space (see Figure 4, blue
coordinates), are selective for small molecular weight compo-
nents. Interestingly, one tissue component unrelated to CPMG
descriptors (i.e., diffusion-edited spectra of ileum) co-mapped
with the infected animal designated ‘t2’, which showed the
highest worm burden. This may indicate an increased degrada-
tion of biological membranes in the small intestine,56 hence,
resulting in increased systemic lipid components. Although
some groupings between biological matrices are evident, for
example, the ileum, colon, and liver map to a similar location
in the hierarchical loadings plot, the transparency of the
individual metabolites contributing to the structure of the
model (e.g., the discrimination between infected and control
samples) is limited. Thus, an exploration of covariance between
metabolites both within and across biological matrices can
generate a clearer picture of potential mechanistic molecular
connectivities.
For the differential candidate biomarkers selected on the
basis of the O-PLS-DA models, correlation structures were
assessed across the full range of tissues and biofluids separately
for the control and infected groups and the differences between
the two correlation matrices compared. While certain relation-
ships across both control and infected correlation matrices
were consistent, for example, the positive association between
the various amino acids in the ileum, or plasma GPC with
plasma lipids, for some metabolite pairs the direction of
correlation was either not preserved (e.g., plasma and colonic
GPC) or even reversed (jejunal myo-inositol and ileal alanine).
Additional correlation analysis between the selected tissue
compartments revealed interesting insight into the systems
dynamics in response to the infection. The most diagnostic
tissue in terms of the number of perturbed metabolites was
the ileum, which is consistent with the localization of the
maturing and adult trematode in the ileum. Urine was also
strongly diagnostic of infection with several metabolites cor-
relating directly with ileal metabolites, for example, a negative
correlation of urinary phenylacetylglycine was found with ileal
ascorbate and glutamine. Two previous studies using high-
performance thin-layer chromatography for the analysis of
urine of E. caproni-infected mice reported altered neutral lipid
profile and amino acids in infected animals.26,57 The fecal water
spectra showed the least degree of intra- or extra-matrix
correlation, which can, at least partially, be explained by the
metagenomic influence as the gut microbial species produce
approximately 60% of the fecal mass and are intra- and
interindividually highly dynamic. For these reasons, fecal
samples are most variable in biochemical composition and
difficult to interpret within a systems context, but can add
important pathway information relating to the influence of the
infection on the microbiota or vice versa. Surprisingly, the fecal
mass profile showed little correlation with the colon, despite
their close physical connection, but is most likely explained
by the low number of compartment-specific infection-induced
changes, which were the driving factor of the pairwise correla-
tion analysis. The association between metabolite levels of
control animals arises due to intrinsic variability of a metabolic
system influenced by genetic and environmental factors. In
turn, the effects of infection, disrupting regulatory activity of
metabolic networks, may change the underlying structure of
metabolite inter-relationships. The correlation analysis thus
offers a way to explore additional information about the
physiological or pathological state of an organism.
The clustered similarity matrix of pairwise correlations
between discriminatory metabolites indicates that some meta-
bolic changes are highly correlated with numerous metabolites,
while others covary with only 1 or 2 other infection-induced
changes in metabolite levels. The number of correlations
between a given candidate biomarker and other metabolites
Figure 4. Hierarchical-PCA scores plot, assessing the weight of
the different biological matrices due to an E. caproni infection.
Initially, separate PCAs have been performed for all the biological
matrices, and subsequently the PCs were extracted from those
models with positive Q2X and/or R2cumX and which showed a
visual separation in the scores plot (i.e., liver, renal cortex, ileum,
colon, spleen, plasma, and urine). Two or 3 extracted PCs from
each chosen compartment formed the sublevel of the hierarchical
analysis. Only the closest time point to the dissection was chosen
for the biofluids (i.e., day 33 postinfection), in order to minimize
time-dependent variation compared to the time point of tissue-
removal (i.e., day 36 postinfection). The loadings plot shows the
distribution of the biomatrices in relation to the 2 groups in the
corresponding scores plot, whereby ‘t’ indicates E. caproni-
infected animals and ‘c’ the uninfected control mice. Of note, two
uninfected control mice (c4 and c10) were excluded from the
global hierarchical analysis due to unsatisfactory water suppres-
sion in the 1D spectra of ileum and urine, respectively. The H-PCA
loadings are composed of the tissues (C, colon; I, ileum; K, renal
cortex; L, liver; P, plasma; U, urine) and the corresponding pulse
program that has been applied for 1H NMR data acquisition (c,
CPMG; d, DOESY; n, 1D pulse sequence).
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Figure 5. Continued.
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may allow estimation of the specificity and utility of that
metabolite as a biomarker of an E. caproni infection. For
instance, it is likely that metabolites which are catholic in their
correlation with other infection-related metabolite changes are
more likely to inform on a global response to the infection at
a systems level, while metabolites demonstrating discriminatory
behavior between infected and control, but which are not
widely correlated to other discriminatory metabolites are more
likely to report on a pathway-specific or localized effect. Plasma
alanine concentrations were increased in the E. caproni-
infected mice and correlated with 10 other infection-related
metabolite changes within and across compartments, including
decreased plasma glucose concentrations, which may be
indicative of an up-regulation of gluconeogenesis. Other me-
tabolites that correlate only within 1 tissue may be more
indicative of localized effects. The inverse correlation of urinary
trimethylamine and phenylacetylglycine, for instance, both of
which can be derived from gut microbial metabolism, suggests
that an E. caproni infection causes disruption of the intestinal
microbiota, which is consistent with observations made for
several other host-parasite models.8-12
Conclusion
This study emphasizes the contribution of multilevel meta-
bolic profiling of host-parasite systems to obtain information
on the pathology and pathway perturbations, and to reveal
information on a panorganismal metabolic level. Furthermore,
a promising approach is utilized for visualizing compartmental
interactions with a view to identifying the metabolic features
(e.g., the candidate biomarkers) of the present infection, and
hence, assess the degree of physiological involvement in disease
mechanisms. The sensitivity of the approach is underlined by
the additional histological analyses of all assessed tissues, which
did not show any obvious infection-induced changes, thus,
illustrating the ability of the applied spectroscopic tools for
detecting sub- and prepathological states. The suitability of
E. caproni as a model trematode has been confirmed in view
of the subtle metabolic findings presented here. An infection
with this intestinal fluke indeed appears to weaken the overall
physiological state of the host by inducing an intestinal
malabsorption of nutrients and affecting both direct and
remote tissue compartments. While the impact of this parasite
may be relatively harmless per se, in co-infection situations, it
may exert a more deleterious effect. For example, the hepatic
manifestation of the low BCAA status could have adverse effects
in the case of a hepatic dysfunction, as the BCAAs are known
to play a key role in hepatic regenerative processes,58 which is
of particular importance in Asian countries due to the high
burden of hepato-biliary trematodes (e.g., Clonorchis sinensis
and Opisthorchis viverrini), and which additionally account for
the highest global rates of liver cancer and associated liver
cirrhosis.59,60
Figure 5. Cluster analysis based on E. caproni infection-induced metabolic interactions between 8 assessed biological matrices. (A)
Correlation structure of control animals demonstrating natural variation due to genetic and experimental individual background; (B)
correlation structure composed of inherent individual variation and the effects of an infection; (C) differential cluster matrix showing
only the remaining effects of the E. caproni infection. Key: co, colon; fe, fecal water; il, ileum; je, jejunum; ki, kidney; li, liver; pl, plasma;
ur, urine. Statistically significant pairwise correlations between metabolite levels with p < 0.05 were explored in the analysis.
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